GlassScriptPhysician profile
Paul Brooks Anthony
NPI 1780610477
$6,287.25
in general payments reported to CMS, 2019-2025
44 companies · $997 in 2025
The $997 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,026 · 2020: $285 · 2021: $636 · 2022: $1,022 · 2023: $1,190 · 2024: $1,131 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,318.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $766.26 | 2019-2025 | |
| Glaxosmithkline, LLC. | $623.70 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $445.07 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $403.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $384.37 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbott Laboratories | $375.26 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $333.41 | 2021-2025 | Viberzi, Linzess, Ubrelvy |
| Sumitomo Pharma America, INC. | $256.54 | 2023-2025 | Gemtesa |
| Amgen INC. | $249.40 | 2019-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $243.82 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $210.86 | 2019-2023 | |
| Exact Sciences Corporation | $207.61 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $174.04 | 2023-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $149.05 | 2019-2024 | Spravato |
| Biohaven Pharmaceuticals, INC. | $134.20 | 2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.